Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Updated : January 6, 2015 4:02 PM IST
Sydney, Jan 5:
Dementia, where a person's cognitive mind, function and memory dissolves, is one of the biggest medical challenges for elderly people.An Australian university has been commissioned by the US-based National Institutes of Health to investigate aspirin's anti-dementia powers, local media reported Monday.
Monash University in Melbourne has begun a 50 million Australian dollar ($41 million) trial called ASPirin in Reducing Events in the Elderly (ASPREE), Xinhua reported. (Read: How to overcome the stigma of dementia)
It is a joint study with the Berman Center for Outcomes and Clinical Research in Minneapolis in the US and involves more than 19,000 Australian patients in the trial. Aspirin's properties revolve around its ability to stop blood platelets clumping together, reducing the risk of heart attacks and strokes. But its active ingredient is salicin, which has an anti-inflammatory effect and is derived from willow trees. (Read: 7 early signs of dementia you should know about)
Read more about Dementia-- causes, symptoms, treatment and prevention
Source: IANS
Photo source: Getty images
For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.
